HOME >> MEDICINE >> NEWS
Omega-3 fatty acids may slow cognitive decline in some patients with very mild Alzheimer's disease

Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, but do not appear to affect those with more advanced cases, according to results of a clinical trial published in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

Alzheimer's disease is a severely debilitating condition that affects thinking, learning and memory, beginning with declines in episodic memory (including memory about events in one's own life), according to background information in the article. Medications are available to treat the symptoms, but these drugs do not affect the underlying cause and progression of the disease. Several studies have shown that eating fish, which is high in omega-3 fatty acids, may protect against Alzheimer's disease, leading researchers to question whether supplements could have similar effects.

Yvonne Freund-Levi, M.D., Karolinska Institutet, Stockholm, Sweden, and colleagues compared the effects of supplements containing two omega-3 fatty acids with placebo in 204 patients with Alzheimer's disease, 174 of whom completed the entire study. For six months, 89 patients (51 women and 38 men) took 1.7 grams of docosahexaenoic acid (DHA) and .6 grams of eicosapentaenoic acid (EPA), while 85 patients (39 women and 46 men) took placebo. For an additional six months, both groups took the omega-3 fatty acids. Patients had physical examinations, which included blood tests and blood pressure measurement, and took cognitive tests at the beginning of the study and at the six- and 12-month marks.

After six months, there was no difference in the rate of cognitive decline between the two groups. However, among a subgroup of 32 patients with very mild cognitive impairment at the beginning of the study, those who took the fatty acids experienced less decline in six months compared with those who took placebo. Among those who took placebo during the first six months, de
'"/>

Contact: Jan Palmblad
jan.palmblad@ki.se
JAMA and Archives Journals
9-Oct-2006


Page: 1 2

Related medicine news :

1. Omega-3 fatty acids may slow down early Alzheimers in some cases
2. The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient
3. Omega-3 offers hope for new anti-breast cancer drugs
4. Can an omega-3 fatty acid slow the progression of Alzheimers disease?
5. Long-term effects of non-alcoholic fatty liver disease
6. Researchers estimate significant fatty liver disease in children
7. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate
8. Patients with nonalcoholic fatty liver disease have an increased risk of heart disease
9. Omega 3 fatty acids influence mood, impulsivity and personality, study indicates
10. Consumption of omega-3 fatty acids unlikely to significantly reduce risk of cancer
11. Northwestern Memorial researchers aim to find answer to halting the progression of fatty liver

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... 2016 , ... NutraPre today announced the nationwide release of ... prevent morning sickness and promote overall heath. Engineered with advanced nanotechnology, this beverage ... water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO Eddie Cameron said. ...
(Date:5/23/2016)... ... 2016 , ... On the occasion of his 25th Anniversary of changing and ... process: , New patients have a consultation and evaluation (done by Dr. Ferdico personally). ... Body Composition Analysis, There are 15 things that each patient gets checked for, ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an article published May 12th on the ... oral health and hygiene. The article points out that, as long as patients are brushing ... become worn and frayed. Of course, these worn-out bristles won’t clean teeth and gum tissue ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an ... an exuberant mood since the birth of her son, Rockwell Lloyd Liu, and notes ... had.” The “Elementary” and “Kill Bill” star explains that, as a career oriented single ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... of high-level representatives from the Japan PMDA, US FDA, industry and academia at ... CDISC standards help format data from clinical trials so that it can be ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016   Purdue Pharma L.P.  today announced ... with Egalet Corporation and Acura Pharmaceuticals, Inc. that ... the agreement the companies will exchange valuable patent ... companies to develop and sell several opioid pain ... reflects the commitment of Purdue Pharma to seek ...
(Date:5/20/2016)... May 20, 2016 - ... Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and ... - This New Study Reveals Selling Opportunities and ... ,What is the future of biologics, ... technological and commercial analysis. Staying ahead in data ...
(Date:5/19/2016)... Cellvizio Highlighted in Physician Presentations and ... 91 st Congress of the Japan Gastroenterological ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... Cellvizio platform is being highlighted at two major ... of May. The first meeting highlighting Cellvizio is ...
Breaking Medicine Technology:
Cached News: